RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
Titel:
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
Auteur:
Ponce Aix, S Novello, S Garon, EB Nakagawa, K Nadal, E Moro-Sibilot, D Alonso Garcia, M Fabre, E Frimodt-Moller, B Zimmermann, AH Visseren-Grul, CM Reck, M